Trial Profile

Retrospective, monocentric observational study of pregnant women with an increased vascular risk and a primary prophylactic anticoagulation with certoparin in an intermediate dose of 8000iU sc od. - PACER-VARP

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 08 Dec 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Certoparin sodium (Primary)
Indications Deep vein thrombosis; Phlebitis; Pulmonary embolism; Thromboembolism; Venous thromboembolism
Focus Therapeutic Use
Acronyms PACER-VARP

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com